Angle Health raises $134 million in Series B funding to enhance its AI-native health benefits platform amidst a transformative U.S. healthcare landscape.

Target Company Overview

Angle Health is a pioneering firm that has introduced the first vertically integrated AI platform for healthcare benefits. Recently, the company secured $134 million in an oversubscribed Series B funding round, which was led by Portage and included participation from several prominent investors such as Blumberg Capital, Mighty Capital, PruVen Capital, and Y Combinator. This funding, which consists of both debt and equity, elevates the total capital raised by Angle to nearly $200 million, aimed at expanding operations to cater to the growing demand for alternative health plan offerings.

Angle Health is at the forefront of a significant transformation within the U.S. healthcare industry, which is valued at $4 trillion. The ongoing changes in this industry reflect an urgent need for innovation, particularly as the Affordable Care Act (ACA) premiums are expected to rise by over 15%, marking the steepest increase since 2018. Angle Health is successfully providing AI-driven solutions that help streamline costs and enhance patient outcomes while delivering tangible value across the healthcare system.

Industry Overview: U.S. Healthcare Sector

The U.S. healthcare industry is undergoing a substantial shift characterized by a demand for cost-efficient healthcare solutions and streamlined operations. Recent scrutiny on billing practices from regulators

View Source

Similar Deals

Oak HC/FT, General Catalyst Chai Discovery

2025

Series B Biotechnology & Medical Research (NEC) United States of America
Oak HC/FT Chai Discovery

2025

Series B Biotechnology & Medical Research (NEC) United States of America
Redpoint Ventures Function Health

2025

Series B Medical & Diagnostic Laboratories United States of America
Five Elms Capital Ritten

2025

Series B Healthcare Facilities & Services (NEC) United States of America
Reach Capital Manifold

2025

Series B Biotechnology & Medical Research (NEC) United States of America
ARCH Venture Partners, GV (Google Ventures) Pelage Pharmaceuticals

2025

Series B Proprietary & Advanced Pharmaceuticals United States of America

Portage

invested in

Angle Health

in 2025

in a Series B deal

Disclosed details

Transaction Size: $134M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert